Results 121 to 130 of about 2,435 (141)
Some of the next articles are maybe not open access.

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

American Journal of Respiratory and Critical Care Medicine, 2022
Sarah Jane Schwarzenberg   +2 more
exaly  

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine, 2021
Isabelle Sermet-Gaudelus   +2 more
exaly  

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

American Journal of Respiratory and Critical Care Medicine, 2021
Samuel Moskowitz   +2 more
exaly  

Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy

Journal of Cystic Fibrosis, 2022
David Young, Shannon Rotolo
exaly  

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles

American Journal of Respiratory and Critical Care Medicine, 2022
Mirjam Stahl   +2 more
exaly  

Home - About - Disclaimer - Privacy